drug protocol number

D419CR00035

drug sponsor

AstraZeneca

drug study

Durvalumab

drug trial site

King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh)

drug status

Ongoing

drug phase